1. Home
  2. > Healthcare Market Trends
Blood Transfusion Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product, Application, and End User

Blood Transfusion Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product, Application, and End User

  • July 2022
  • 183 pages
  • ID: 6316328
  • Format: PDF
  • The Insight Partners

Summary

Table of Contents

Search Inside

The global blood transfusion diagnostics market is expected to grow from US$ 4,096.93 million in 2021 to US$ 6,483.75 million by 2028. It is estimated to grow at a CAGR of 6.9% from 2022 to 2028. The report highlights prevailing trends and factors driving the market growth.

The growth of the global blood transfusion diagnostics market is attributed to the rapid increase in chronic diseases and the need for blood transfusion due to the rise in organ transplant surgeries. However, the problems associated with blood transfusion services hinder the overall market growth.
Blood transfusion diagnostics refers to tests performed on blood and blood components before they are transfused to patients.A blood transfusion is a common procedure in which donated blood or blood components are transfused into the patient’s body through an intravenous line (IV).

Each unit of blood must undergo blood typing, which refers to identification of blood type and blood screening, including disease detection tests to avoid side effects or transmission of infection. Blood screening before transfusion is performed through instruments, kits, and reagents to identify various diseases, such as HIV, hepatitis B, hepatitis C, Zika, and different viruses and infections.
According to the data published by the National Institute of Cancer Prevention and Research (NICPR) and the Indian Council of Medical Research (ICMR), the yearly prevalence of cancer in India is estimated at ~2.25 million, leading to numerous surgical procedures.
As per a 2019 study, titled "Challenges of blood transfusions in ?-thalassemia," approximately 26,000 patients with transfusion-dependent ?-thalassemia (TDT) are born every year, and around 90% of these births occur in low- or middle-income countries.Hemoglobinopathies, comprising sickle cell disease, are endemic in Africa, Asia, the Middle East, the Indian subcontinent, and the Mediterranean region.

They are currently the most common rare inherited genetic diseases in Europe.Due to migration, hemoglobinopathies have been increasingly common in parts of North America and Northern and Western Europe, where they are not indigenous, and in their indigenous countries of Southern Europe.

This led to an increase in the prevalence of ?-thalassemia.Approximately 800 patients with thalassemia are registered in the UK National Haemoglobinopathy Registry, with around 500 patients undergoing regular blood transfusions.

Therefore, blood transfusion diagnostics are widely used in various surgical procedures, such as cardiac surgery and other invasive procedures.
Chronic diseases, such as cancer, cardiovascular diseases, and renal disorders, are major causes of human death worldwide.These conditions are generally treated via surgical procedures, which are associated with a chance of excessive blood loss.

Fresh blood is infused into patients to maintain their blood levels.Blood transfusion diagnostics are used during the blood infusion or reinfusion processes.

Hence, the global blood transfusion diagnostics market is rising with the rapid increase in chronic diseases.
Based on product, the global blood transfusion diagnostics market is bifurcated into instruments & kits and reagents.In 2021, the instruments & kits segment held a larger market share.

The same segment is expected to register a higher CAGR in the market from 2022 to 2028.Based on application, the market is bifurcated into disease screening and blood grouping.

The disease screening segment held a larger market share in 2021 and is expected to register a higher CAGR during the forecast period.Based on end user, the market is segmented into blood banks, hospitals, diagnostic laboratories, and plasma fractionation companies.

The blood banks segment held the largest market share in 2021. The same segment is expected to register the highest CAGR in the global blood transfusion diagnostics market from 2022 to 2028.
Impact of COVID-19 Pandemic on Global Blood Transfusion Diagnostics Market
The COVID-19 pandemic negatively impacted blood services operations worldwide.Blood collection was affected due to the decrease in donor availability caused by avoidance of public places, social distancing policies, and cancellation of blood drives.

The negative impact on blood collection led to a reduction in blood transfusion due to insufficient blood supply.For instance, a research conducted by RMIT University, Australia, titled "The Impact of COVID-19 on Blood Transfusion Services: A Systematic Review and Meta-Analysis," revealed that the average decrease in blood donations was found to be 38% in the country.

To cope with the blood shortage, campaigns were implemented to appeal for blood donation, raise public awareness about the importance of blood donation, and gain donors’ confidence in safe blood donation. For instance, upon Korean Red Cross Blood Services’ (KRCBS) request, the Ministry of Health and Welfare (MoHW) approved the relaxation of the geographical restrictions regarding indigenous malaria, thus enabling the collection of more than 23,000 units of whole blood.
Furthermore, doctors took the initiative to control unnecessary blood transfusions.For instance, according to the news published by ABC Science, in March 2022, Australian doctors warned against unnecessary blood transfusions in Australian hospitals.

Also, as medical and surgical practices were restricted, the need for blood transfusions was decreased too. Thus, the above factors and instances indicate that the blood transfusion diagnostic market witnessed a negative COVID-19 impact.
Various organic and inorganic strategies are adopted by companies operating in the global blood transfusion diagnostics market.The organic strategies mainly include product launches and product approvals.

Further, inorganic growth strategies witnessed in the market are acquisitions, collaborations, and partnerships.These growth strategies allow the market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall market growth.

Further, acquisition and partnership strategies help the market players strengthen their customer base and expand their product portfolios. A few significant developments by key players in the global blood transfusion diagnostics market are listed below.
• In July 2022, Quotient Limited announced an agreement with InfYnity Biomarkers, an R&D firm dedicated to utilizing biomarkers for managing infectious and immunology diseases. The two companies will partner to advance the safety and effectiveness of infectious disease testing by leveraging Quotient’s MosaiQ solution.
• In November 2021, Roche announced the launch of the cobas 5800 System, a new molecular laboratory instrument, in countries accepting the CE mark. The cobas 5800 System helps address challenges that laboratories are facing from increased patient testing, reimbursement complexities, and the need for a more diverse testing menu while providing meaningful and timely results.

While preparing the report on the global blood transfusion diagnostics market, a few major primary and secondary sources are the National Health and Medical Research Council (NHMRC), the Government of Canada, and the Kidney Research and Clinical Practice (KRCP).

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Grace helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

South America Blood Transfusion Diagnostics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product, Application, and End User

  • $ 3000
  • November 2022
  • 124 pages

The SAM blood transfusion diagnostics market is expected to grow from US$ 217.55 million in 2022 to US$ 302.89 million by 2028. It is estimated to grow at a CAGR of 5.7% from 2022 to 2028. Technological ...

  • Brazil
  • Argentina
  • Diagnostics
  • Blood Transfusion
  • Industry analysis
  • Diagnostic Revenue
  • Health Expenditure

ref:plp2022

Reportlinker.com © Copyright 2023. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on